Comment by openrisk
2 days ago
Yes, but now it doesn't even have national champions. The last one standing with some pretense at being still with the times is probably ASML.
One wonders whether at any point anybody will ask any tough questions about where Europe is heading as far as technology goes.
I would put Novo Nordisk up there too. Not sure how Eli Lilly is doing so much better though, which I presume for both is due to advancing GLP-1s, but I thought Novo was first to market.
Lots of people are. The answer appears to be “down the drain”.
People forget that for a long time ASML was government backed